Scientific Advisory Committee on Medical Devices used in Cardiovascular System - Agenda - November 28, 2014
- Place: Holland Cross, Tower B, Room 2048
- Date and time: November 28, 2014, 7:30 am to 16:00pm
- Chairperson: Dr. John Ducas
- Science Advisor: Hripsime Shahbazian
- Participants: SAC MDUCS Members, Health Canada
- Scientific & Regulatory Officers: Caroline Hunt
- 7:30-8:00
- Refreshments
- 8:00-8:10
-
Opening Remarks:
Review of the Agenda, Declaration of Affiliations and Interest.
Barbara J Sabourin (DGO,TPD) & Dr. John Ducas (SAC-MDUCS Chair) - 8:10-8:25
-
Summary of how Information from Previous Meetings is Being Used
Mr. Kevin Day (Medical Devices Bureau, TPD) - 8:25-10:10
-
Question 1: Renal Denervation - Next Steps for a Regulatory Body, Typical Use, Requirements for New Licenses
Speaker: Dr. Raj Padwal - 10:10-10:25
- Break
- 10:25-11:25
-
Question 2: Use of LAA Closure Devices, Clinical Requirements and Patient Populations
Speaker: Dr. Réda Ibrahim - 11:25-12:10
-
Question 3: TAVI - Clinically Significant Technological Features
Speaker: Dr. John Webb (Committee Member) - 12:10-1:00
- Lunch
- 1:00-2:30
-
Question 4: Aortic Dissection
Speakers: Dr. Thomas Forbes and Dr. Prasad Jetty - 2:30-3:15
-
Question 5: Intracompatibility between IS-4 Leads and Cans
Speaker: Dr. Raymond Yee (Committee Member) - 3:15-3:55
-
Late Breaking Issues in Cardiovascular Devices
Bioabsorbable Vascular Scaffolds and Their Appropriate Patient Populations (Committee Discussion - Introduction by Dr. Ian Aldous)
Responses to dual antiplatelet therapy duration clinical trial results from AHA (Committee Discussion - Introduction by Kevin Day) - 3:55-4:00
- Next Steps, Closing Remarks and Adjournment of Meeting
Report a problem or mistake on this page
- Date modified: